Research output per year
Research output per year
Personal profile
Research interests
I am interested in the pathophysiology and treatment of neurologic infectious diseases, with a particular emphasis on HIV/AIDS associated neurologic diseases. At present I am active in clinical trials involving HIV, HIV associated cognitive disorder, HIV associated peripheral neuropathy and pain, HIV-2, and progressive multifocal leukoencephalopathy.
Clinical interests
HIV neurological disorders, peripheral neuropathy, HIV related dementia, progressive multifocal leukoencephalopathy, PML, neurologic infection, multiple sclerosis.
Fingerprint
Dive into the research topics where David Clifford is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Dominantly Inherited Alzheimer's Disease–Trials Unit, Apr 2025, In: The Lancet Neurology. 24, 4, p. 316-330 15 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Biopsychosocial phenotypes in people with HIV in the CHARTER cohort
Tang, B., Ellis, R. J., Vaida, F., Umlauf, A., Franklin, D. R., Dastgheyb, R., Rubin, L. H., Riggs, P. K., Iudicello, J. E., Clifford, D. B., Moore, D. J., Heaton, R. K. & Letendre, S. L., 2024, In: Brain Communications. 6, 4, fcae224.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials
Liu, H., Li, J., Ziegemeier, E., Adams, S., McDade, E., Clifford, D. B., Cao, Y., Wang, G., Li, Y., Mills, S. L., Santacruz, A. M., Belyew, S., Grill, J. D., Snider, B. J., Mummery, C. J., Surti, G., Hannequin, D., Wallon, D., Berman, S. B. & Jimenez-Velazquez, I. Z. & 19 others, , May 2024, In: The journal of prevention of Alzheimer's disease. 11, 3, p. 558-566 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial
Wagemann, O., Liu, H., Wang, G., Shi, X., Bittner, T., Scelsi, M. A., Farlow, M. R., Clifford, D. B., Supnet-Bell, C., Santacruz, A. M., Aschenbrenner, A. J., Hassenstab, J. J., Benzinger, T. L. S., Gordon, B. A., Coalier, K. A., Cruchaga, C., Ibanez, L., Perrin, R. J., Xiong, C. & Li, Y. & 30 others, , Jun 10 2024, In: JAMA Neurology. 81, 6, p. 582-593 12 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
Wang, G., Li, Y., Xiong, C., Benzinger, T. L. S., Gordon, B. A., Hassenstab, J., Aschenbrenner, A. J., McDade, E., Clifford, D. B., Libre-Guerra, J. J., Shi, X., Mummery, C. J., van Dyck, C. H., Lah, J. J., Honig, L. S., Day, G., Ringman, J. M., Brooks, W. S., Fox, N. C. & Suzuki, K. & 5 others, , Apr 2024, In: Alzheimer's and Dementia. 20, 4, p. 2698-2706 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations